Logo image of MHLD

MAIDEN HOLDINGS LTD (MHLD) Stock Fundamental Analysis

NASDAQ:MHLD - Nasdaq - BMG5753U1128 - Common Stock - Currency: USD

1.17  +0.09 (+8.33%)

After market: 1.12 -0.05 (-4.27%)

Fundamental Rating

0

We assign a fundamental rating of 0 out of 10 to MHLD. MHLD was compared to 143 industry peers in the Insurance industry. MHLD may be in some trouble as it scores bad on both profitability and health. MHLD does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

MHLD had negative earnings in the past year.
In the past year MHLD has reported a negative cash flow from operations.
The reported net income has been mixed in the past 5 years: MHLD reported negative net income in multiple years.
MHLD had a negative operating cash flow in each of the past 5 years.
MHLD Yearly Net Income VS EBIT VS OCF VS FCFMHLD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M -1B

1.2 Ratios

MHLD's Return On Assets of -15.27% is on the low side compared to the rest of the industry. MHLD is outperformed by 94.41% of its industry peers.
The Return On Equity of MHLD (-444.69%) is worse than 96.50% of its industry peers.
Industry RankSector Rank
ROA -15.27%
ROE -444.69%
ROIC N/A
ROA(3y)-4.94%
ROA(5y)-1.43%
ROE(3y)-146.93%
ROE(5y)-79.11%
ROIC(3y)N/A
ROIC(5y)N/A
MHLD Yearly ROA, ROE, ROICMHLD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for MHLD so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MHLD Yearly Profit, Operating, Gross MarginsMHLD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 -200 -300

More info and screens

0

2. Health

2.1 Basic Checks

MHLD has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, MHLD has more shares outstanding
The debt/assets ratio for MHLD is higher compared to a year ago.
MHLD Yearly Shares OutstandingMHLD Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
MHLD Yearly Total Debt VS Total AssetsMHLD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

A Debt/Equity ratio of 5.64 is on the high side and indicates that MHLD has dependencies on debt financing.
MHLD has a Debt to Equity ratio of 5.64. This is amonst the worse of the industry: MHLD underperforms 96.50% of its industry peers.
Industry RankSector Rank
Debt/Equity 5.64
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACCN/A
MHLD Yearly LT Debt VS Equity VS FCFMHLD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B -1B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
MHLD Yearly Current Assets VS Current LiabilitesMHLD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

0

3. Growth

3.1 Past

MHLD shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -430.18%.
Looking at the last year, MHLD shows a very negative growth in Revenue. The Revenue has decreased by -32.94% in the last year.
MHLD shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -37.29% yearly.
EPS 1Y (TTM)-430.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-671.82%
Revenue 1Y (TTM)-32.94%
Revenue growth 3Y-17.22%
Revenue growth 5Y-37.29%
Sales Q2Q%-104.2%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MHLD Yearly Revenue VS EstimatesMHLD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B
MHLD Yearly EPS VS EstimatesMHLD Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 0 -2 -4

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MHLD. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MHLD Price Earnings VS Forward Price EarningsMHLD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MHLD Per share dataMHLD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 -1 -1.5 -2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MHLD!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MAIDEN HOLDINGS LTD

NASDAQ:MHLD (4/25/2025, 8:23:47 PM)

After market: 1.12 -0.05 (-4.27%)

1.17

+0.09 (+8.33%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)03-10 2025-03-10
Earnings (Next)05-13 2025-05-13
Inst Owners33.42%
Inst Owner Change-0.05%
Ins Owners21.28%
Ins Owner Change1.05%
Market Cap116.40M
Analysts43.33
Price TargetN/A
Short Float %3.89%
Short Ratio7.22
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.08
P/FCF N/A
P/OCF N/A
P/B 2.58
P/tB 2.58
EV/EBITDA N/A
EPS(TTM)-2.02
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.68
FCFYN/A
OCF(TTM)-0.68
OCFYN/A
SpS0.56
BVpS0.45
TBVpS0.45
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -15.27%
ROE -444.69%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-4.94%
ROA(5y)-1.43%
ROE(3y)-146.93%
ROE(5y)-79.11%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 5.64
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score2
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-430.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-671.82%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-32.94%
Revenue growth 3Y-17.22%
Revenue growth 5Y-37.29%
Sales Q2Q%-104.2%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-575.37%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-12.83%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-12.83%
OCF growth 3YN/A
OCF growth 5YN/A